{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:07:52Z","timestamp":1771024072288,"version":"3.50.1"},"reference-count":30,"publisher":"Japanese Circulation Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2025,11,10]]},"DOI":"10.1253\/circrep.cr-25-0152","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T22:07:49Z","timestamp":1758060469000},"page":"1021-1028","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Importance of Phosphodiesterase 3 Inhibitors on Outcomes in Patients With Cardiogenic Shock\u3000\u2015 A Systematic Review \u2015"],"prefix":"10.1253","volume":"7","author":[{"given":"Masahiro","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Hosoya","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sakakibara Heart Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Hanada","sequence":"additional","affiliation":[{"name":"Graduate School of Medicine Medical Science Course Emergency and Disaster Medicine, Hirosaki University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Osawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Tsukuba Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology\/Coronary Care Unit, Kyushu University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Steel Memorial Muroran Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Katasako-Yabumoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Ishizu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Tsukuba Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Kirigaya","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yokohama City University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Intensive Care, Nippon Medical School Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutaka","family":"Hashiba","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yokosuka General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruo","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Tsujimoto","sequence":"additional","affiliation":[{"name":"Scientific Research WorkS Peer Support Group (SRWS-PSG)"},{"name":"Oku Medical Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Migaku","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Emergency and Critical Care Center, Dokkyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Tahara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nonogi","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Matoba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Japan Resuscitation Council (JRC) Cardiogenic Shock (CS) Task Force and the Guideline Editorial Committee on behalf of the Japanese Circulation Society (JCS) Emergency and Critical Care Committee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Sarma D, Jentzer JC. Cardiogenic shock: Pathogenesis, classification, and management. <i>Crit Care Clin<\/i> 2024; 40: 37\u201356.","DOI":"10.1016\/j.ccc.2023.05.001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Thiele H, de Waha-Thiele S, Freund A, Zeymer U, Desch S, Fitzgerald S. Management of cardiogenic shock. <i>EuroIntervention<\/i> 2021; 17: 451\u2013465.","DOI":"10.4244\/EIJ-D-20-01296"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Jentzer JC, P\u00f6ss J, Schaubroeck H, Morrow DA, Hollenberg SM, Mebazaa A. Advances in the management of cardiogenic shock. <i>Crit Care Med<\/i> 2023; 51: 1222\u20131233.","DOI":"10.1097\/CCM.0000000000005919"},{"key":"4","unstructured":"4. Basir MB, Lemor A, Gorgis S, Patel KC, Kolski BC, Bharadwaj AS. Early utilization of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The National Cardiogenic Shock Initiative. <i>J Am Heart Assoc<\/i> 2023; 12: e031401."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Thiele H, M\u00f8ller JE, Henriques JPS, Bogerd M, Seyfarth M, Burkhoff D, et al. Temporary mechanical circulatory support in infarct-related cardiogenic shock: An individual patient data meta-analysis of randomised trials with 6-month follow-up. <i>Lancet<\/i> 2024; 404: 1019\u20131028.","DOI":"10.1016\/S0140-6736(24)01448-X"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tuttle RR. Dobutamine: Development of a new catecholamine to selectively increase cardiac contractility. <i>Circ Res<\/i> 1975; 36: 185\u2013196.","DOI":"10.1161\/01.RES.36.1.185"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Schumann J, Henrich EC, Strobl H, Prondzinsky R, Weiche S, Thiele H, et al. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. <i>Cochrane Database Syst Rev<\/i> 2018; 1: CD009669.","DOI":"10.1002\/14651858.CD009669.pub3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Uhlig K, Efremov L, Tongers J, Frantz S, Mikolajczyk R, Sedding D, et al. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. <i>Cochrane Database Syst Rev<\/i> 2020; 11: CD009669.","DOI":"10.1002\/14651858.CD009669.pub4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nakashima T, Kondo T, Nakata J, Saku K, Kawakami S, Kuwabara M, et al. Expert consensus statement on the evaluation, treatment, and transfer of cardiogenic shock using a Delphi method approach: A report of the Japan Critical Care Cardiology Committee (J4CS). <i>Circ J<\/i> 2025; 89: 998\u20131011.","DOI":"10.1253\/circj.CJ-25-0192"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. <i>BMJ<\/i> 2021; 372: n71.","DOI":"10.1136\/bmj.n71"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sch\u00fcnemann HJ, Mustafa RA, Brozek J, Santesso N, Bossuyt PM, Steingart KR, et al. GRADE guidelines: 22. The GRADE approach for tests and strategies-from test accuracy to patient-important outcomes and recommendations. <i>J Clin Epidemiol<\/i> 2019; 111: 69\u201382.","DOI":"10.1016\/j.jclinepi.2019.02.003"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zhang Y, Akl EA, Sch\u00fcnemann HJ. Using systematic reviews in guideline development: The GRADE approach. <i>Res Synth Methods<\/i> 2018; 10: 312\u2013329.","DOI":"10.1002\/jrsm.1313"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fuhrmann JT, Schmeisser A, Schulze MR, Wunderlich C, Schoen SP, Rauwolf T, et al. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. <i>Crit Care Med<\/i> 2008; 36: 2257\u20132266.","DOI":"10.1097\/CCM.0b013e3181809846"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Mathew R, Di Santo P, Jung RG, Marbach JA, Hutson J, Simard T. Milrinone as compared with dobutamine in the treatment of cardiogenic shock. <i>N Engl J Med<\/i> 2021; 385: 516\u2013525.","DOI":"10.1056\/NEJMoa2026845"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kikuchi M, Tahara Y, Yamaguchi J, Nakashima T, Nomura O, Tanaka A, et al. Executive summary: Acute coronary syndrome in the Japan Resuscitation Council Guidelines for Resuscitation 2020. <i>Circ J<\/i> 2023; 87: 866\u2013878.","DOI":"10.1253\/circj.CJ-23-0096"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Saito Y, Tateishi K, Kobayashi Y. Clinical review of cardiogenic shock after acute myocardial infarction: Revascularization, mechanical circulatory support, and beyond. <i>Circ Rep<\/i> 2024; 7: 6\u201314.","DOI":"10.1253\/circrep.CR-24-0141"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. van Diepen S, P\u00f6ss J, Senaratne JM, Gage A, Morrow DA. Mixed cardiogenic shock: A proposal for standardized classification, a hemodynamic definition, and framework for management. <i>Circulation<\/i> 2024; 150: 1459\u20131468.","DOI":"10.1161\/CIRCULATIONAHA.124.069508"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Marbach JA, Stone S, Schwartz B, Pahuja M, Thayer KL, Faugno AJ, et al. Lactate clearance is associated with improved survival in cardiogenic shock: A systematic review and meta-analysis of prognostic factor studies. <i>J Card Fail<\/i> 2021; 27: 1082\u20131089.","DOI":"10.1016\/j.cardfail.2021.08.012"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Beurton A, Ducrocq N, Auchet T, Joineau-Groubatch F, Falanga A, Kimmoun A, et al. Beneficial effects of norepinephrine alone on cardiovascular function and tissue oxygenation in a pig model of cardiogenic shock. <i>Shock<\/i> 2016; 46: 214\u2013218.","DOI":"10.1097\/SHK.0000000000000579"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Markart S, Hermann A, Chiari F, Heinz G, Speidl WS, Lenz M, et al. Urinary output as a predictor of mortality in cardiogenic shock: An explorative retrospective analysis. <i>J Clin Med<\/i> 2024; 13: 7706.","DOI":"10.3390\/jcm13247706"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nitta M, Nakano S, Kaneko M, Fushimi K, Hibi K, Shimizu S. In-hospital mortality in patients with cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation with concomitant use of impella vs. intra-aortic balloon pump: A retrospective cohort study using a Japanese claims-based database. <i>Circ J<\/i> 2024; 88: 1276\u20131285.","DOI":"10.1253\/circj.CJ-23-0758"},{"key":"22","unstructured":"22. Vallet B, Dupuis B, Chopin C. Dobutamine: Mechanisms of action and use in acute cardiovascular pathology. <i>Ann Cardiol Angeiol (Paris)<\/i> 1991; 40: 397\u2013402."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hasegawa GR. Milrinone, a new agent for the treatment of congestive heart failure. <i>Clin Pharm<\/i> 1986; 5: 201\u2013205.","DOI":"10.1093\/ajhp\/43.4.1077"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Vincent JL, L\u00e9on M, Berr\u00e9 J. The role of enoximone in the treatment of cardiogenic shock. <i>Cardiology<\/i> 1990; 77(Suppl 3): 21\u201326; discussion 27\u201333.","DOI":"10.1159\/000174667"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Francis GS, Bartos JA, Adatya S. Inotropes. <i>J Am Coll Cardiol<\/i> 2014; 63: 2069\u20132078.","DOI":"10.1016\/j.jacc.2014.01.016"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, et al. Levosimendan efficacy and safety: 20 years of SIMDAX in clinical use. <i>J Cardiovasc Pharmacol<\/i> 2020; 76: 4\u201322.","DOI":"10.1097\/FJC.0000000000000859"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Nieminen MS, Akkila J, Hasenfuss G, Kleber FX, Lehtonen LA, Mitrovic V, et al. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. <i>J Am Coll Cardiol<\/i> 2000; 36: 1903\u20131912.","DOI":"10.1016\/S0735-1097(00)00961-X"},{"key":"28","unstructured":"28. Kitai T, Kohsaka S, Kato T, Kato E, Sato K, Teramoto K, et al. JCS\/JHFS 2025 guideline on diagnosis and treatment of heart failure. <i>J Card Fail<\/i> 2025; 27: S1071-9164(25)00100-9."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kishi T, Sunagawa K. Baroreflex sensitivity might predict responders to milrinone in patients with heart failure. <i>Int Heart J<\/i> 2010; 51: 411\u2013415.","DOI":"10.1536\/ihj.51.411"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Boldt J, Suttner S. Combined use of ultra-short acting beta-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximone. <i>Expert Opin Pharmacother<\/i> 2007; 8: 2135\u20132147.","DOI":"10.1517\/14656566.8.13.2135"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/7\/11\/7_CR-25-0152\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T03:24:31Z","timestamp":1763177071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/7\/11\/7_CR-25-0152\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-25-0152","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"article-number":"CR-25-0152"}}